Combined Smoking Cues Enhance Reactivity and Predict Immediate Subsequent Smoking.


Journal

Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco
ISSN: 1469-994X
Titre abrégé: Nicotine Tob Res
Pays: England
ID NLM: 9815751

Informations de publication

Date de publication:
04 01 2019
Historique:
received: 16 08 2017
accepted: 17 01 2018
pubmed: 26 1 2018
medline: 8 1 2020
entrez: 26 1 2018
Statut: ppublish

Résumé

Cue reactivity (CR) research has reliably demonstrated robust cue-induced responding among smokers exposed to common proximal smoking cues (eg, cigarettes, lighter). More recent work demonstrates that distal stimuli, most notably the actual environments in which smoking previously occurred, can also gain associative control over craving. In the real world, proximal cues always occur within an environment; thus, a more informative test of how cues affect smokers might be to present these two cue types simultaneously. Using a combined-cue counterbalanced CR paradigm, the present study tested the impact of proximal (smoking and neutral) + personal environment (smoking and nonsmoking places) pictorial cues, on smokers' subjective and behavioral CR; as well as the extent to which cue-induced craving predicts immediate subsequent smoking in a within-subjects design. As anticipated, the dual smoking cue combination (ProxS + EnvS) led to the greatest cue-induced craving relative to the other three cue combinations (ProxS + EnvN, ProxN + EnvS, and ProxN ± EnvN), ps < .004. Dual smoking cues also led to significantly shorter post-trial latencies to smoke, ps < .01. Overall CR difference score (post-trial craving minus baseline craving) was predictive of subsequent immediate smoking indexed by: post-trial latency to smoke [B = -2.69, SE = 9.02; t(143) = -2.98, p = .003]; total puff volume [B = 2.99, SE = 1.13; t(143) = 2.65, p = .009]; and total number of puffs [B = .053, SE = .027; t(143) = 1.95, p = .05]. The implications of these findings for better understanding the impact of cues on smoking behavior and cessation are discussed. This novel cue reactivity study examined smokers' reactivity to combined proximal and distal smoking cues. Exposure to a combination of two smoking cues (proximal and environment) led to the greatest increases in cue-induced craving and smoking behavior compared to all other cue combinations. Further, the overall magnitude of cue-induced craving was found to significantly predict immediate subsequent smoking. This work provides new insight on how exposure to various cues and cue combinations directly affect smokers' craving and actual smoking behavior, as well as the relationship between those two indices of reactivity.

Identifiants

pubmed: 29370401
pii: 4821301
doi: 10.1093/ntr/nty009
pmc: PMC6329405
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

241-248

Subventions

Organisme : NIDA NIH HHS
ID : R01 DA023646
Pays : United States

Références

Exp Clin Psychopharmacol. 2001 May;9(2):183-90
pubmed: 11518094
Addiction. 2009 Oct;104(10):1617-8
pubmed: 19558572
Psychiatry Res. 2011 Jul 30;188(2):286-8
pubmed: 21550670
Addict Behav. 1985;10(3):249-56
pubmed: 4083102
Addiction. 1999 Mar;94(3):327-40
pubmed: 10605857
Nicotine Tob Res. 2012 Dec;14(12):1418-25
pubmed: 22416115
Psychol Addict Behav. 2005 Sep;19(3):263-70
pubmed: 16187804
Addict Behav. 2013 Feb;38(2):1527-1531
pubmed: 22726579
Drug Alcohol Depend. 2017 Oct 1;179:8-12
pubmed: 28735078
Drug Alcohol Depend. 2010 Sep 1;111(1-2):58-63
pubmed: 20510552
Psychopharmacology (Berl). 1996 Jun;125(3):202-8
pubmed: 8815954
J Exp Anal Behav. 1970 Jan;13(1):75-81
pubmed: 5415042
Addict Behav. 2006 Apr;31(4):702-10
pubmed: 15979814
Psychopharmacology (Berl). 2017 Oct;234(19):2911-2917
pubmed: 28721480
Drug Alcohol Depend. 2017 Jul 1;176:1-6
pubmed: 28460322
Exp Clin Psychopharmacol. 1998 Feb;6(1):45-53
pubmed: 9526145
Addiction. 2010 Feb;105(2):364-72
pubmed: 19922514
Alcohol Clin Exp Res. 1997 Feb;21(1):101-7
pubmed: 9046380
Psychopharmacology (Berl). 2010 Feb;208(3):337-51
pubmed: 19960187
Psychol Assess. 2009 Dec;21(4):486-97
pubmed: 19947783
Addiction. 1997 Jan;92(1):15-26
pubmed: 9060194
Biol Psychiatry. 2010 Apr 15;67(8):722-9
pubmed: 20172508
Nicotine Tob Res. 2006 Jun;8(3):361-9
pubmed: 16801294
J Abnorm Psychol. 2013 Feb;122(1):264-80
pubmed: 22708884
Addict Behav. 1995 Sep-Oct;20(5):657-73
pubmed: 8712062
Exp Clin Psychopharmacol. 2001 Nov;9(4):399-408
pubmed: 11764016
Addiction. 2002 Feb;97(2):155-67
pubmed: 11860387
Exp Clin Psychopharmacol. 1998 May;6(2):179-86
pubmed: 9608350
Neuropsychopharmacology. 2016 Feb;41(3):877-85
pubmed: 26179147
Nicotine Tob Res. 2013 Dec;15(12):2081-7
pubmed: 23873978
Addict Behav. 1989;14(4):419-28
pubmed: 2782124
Psychopharmacology (Berl). 2010 Dec;212(4):537-49
pubmed: 20703450
Nicotine Tob Res. 2012 Apr;14(4):383-7
pubmed: 22140145
Exp Clin Psychopharmacol. 2008 Jun;16(3):207-14
pubmed: 18540780
Behav Res Ther. 1988;26(3):225-33
pubmed: 3408457
Br J Addict. 1991 Sep;86(9):1119-27
pubmed: 1932883
J Consult Clin Psychol. 2004 Dec;72(6):1136-43
pubmed: 15612859
Psychopharmacology (Berl). 2010 May;210(1):25-34
pubmed: 20217051
Exp Clin Psychopharmacol. 2000 Feb;8(1):68-74
pubmed: 10743906
J Stud Alcohol. 1995 Mar;56(2):202-6
pubmed: 7760567
Addiction. 2002 Sep;97(9):1219-21
pubmed: 12199838
J Pers Soc Psychol. 1984 Nov;47(5):1105-17
pubmed: 6520704
Addiction. 2009 Oct;104(10):1610-6
pubmed: 19426293
J Abnorm Psychol. 1988 May;97(2):133-52
pubmed: 3290304
Exp Clin Psychopharmacol. 2006 Feb;14(1):12-9
pubmed: 16503701
Addiction. 2009 Oct;104(10):1618-9
pubmed: 19558571
Addict Behav. 1991;16(6):467-79
pubmed: 1801570
Exp Clin Psychopharmacol. 2012 Dec;20(6):473-8
pubmed: 22889039
Addict Behav. 2017 Apr;67:49-52
pubmed: 28012965
Exp Clin Psychopharmacol. 2015 Apr;23(2):90-6
pubmed: 25730416
J Abnorm Psychol. 2005 Feb;114(1):153-64
pubmed: 15709822

Auteurs

Cynthia A Conklin (CA)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.

F Joseph McClernon (FJ)

Department of Psychiatry and Behavioral Sciences, Duke University, Durham, NC.

Elizabeth J Vella (EJ)

Department of Psychology, University of Southern Maine, Portland, ME.

Christopher J Joyce (CJ)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.

Ronald P Salkeld (RP)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.

Craig S Parzynski (CS)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.

Lee Bennett (L)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH